HENWOOD GERALDINE (President and CEO) purchased 97.8% of their position (1.20K shares) of BAUDAX BIO, INC. on the open market
Open‑market purchase worth $3.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/19/2022ACC: 0001062993-22-024038
DirectorOfficer· President and CEO
Since Nov 2019
+1.20K
Net shares
Net buyer
$3.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.20K
Price / share
$2.55
Trade value
$3.06K
% of position
97.8%
12/15/2022
1.23K→2.43K
Total
Net shares
+1.20K
Net value
$3.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2022 | P · Purchase | +1.20K | $2.55 | $3.06K | 97.8% | 1.23K | 2.43K |
| Total | +1.20K | $3.06K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned14.00
Total
14.00 indirect14.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.00 | Indirect |
| Total | 14.00 | 14.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported